Trimarchi F, De Luca F, Vanelli M, Benvenga S, Siracusano M F, Volta C, Bernasconi S
Eur J Pediatr. 1984 Sep;142(4):253-6. doi: 10.1007/BF00540246.
Significant high titres (1:400-1:25,600) of circulating thyroid microsomal antibodies (MCHA) were found in the sera of 5 out of 59 non-ketoacidotic, insulin-dependent diabetic (IDDM) patients (mean age 14.5 years). Among these five patients (four females, one male), all of whom were over 11 years, two also had thyroglobulin antibodies. Increased thyrotropin (TSH) response to TRH was found in 3/5 MCHA positive patients and in 3/54 without circulating MCHA. Serum thyroxine (T4) and free T4 (FT4) average values were significantly lower (P less than 0.01 and P less than 0.001) in diabetics (7.1 +/- 1.8 micrograms/dl and 10.2 +/- 3.1 pg/ml, means +/- SD) as compared to normal sex and age matched controls (8.9 +/- 1.9 micrograms/dl and 12.2 +/- 2.2 pg/ml, respectively). T4 and FT4 values were inversely related to the duration of the disease. Subnormal T4 values were found in six (five females and one male) patients, four of whom had subnormal FT4 values. No patient had low triiodothyronine (T3) and high reverse T3 (rT3) values, i.e. none displayed the biochemical pattern of the 'low T3 syndrome' described with ketoacidotic status. This indicates also a satisfactory compensation of IDDM in all the patients. At the time of study no patient (including also those with circulating MCHA and TGHA and with TSH hyper-response to TRH) showed either thyroid size enlargement or clinical features of thyroid dysfunction including impaired growth and bone age retardation.
在59例非酮症酸中毒的胰岛素依赖型糖尿病(IDDM)患者(平均年龄14.5岁)中,有5例患者血清中检测到高滴度(1:400 - 1:25,600)的循环甲状腺微粒体抗体(MCHA)。在这5例患者(4例女性,1例男性)中,年龄均超过11岁,其中2例还伴有甲状腺球蛋白抗体。在5例MCHA阳性患者中有3例以及54例无循环MCHA的患者中有3例,促甲状腺激素(TSH)对促甲状腺激素释放激素(TRH)的反应增强。与年龄和性别匹配的正常对照组相比,糖尿病患者的血清甲状腺素(T4)和游离T4(FT4)平均值显著降低(P < 0.01和P < 0.001)(分别为7.1 ± 1.8 μg/dl和10.2 ± 3.1 pg/ml,均值 ± 标准差),而对照组分别为8.9 ± 1.9 μg/dl和12.2 ± 2.2 pg/ml。T4和FT4值与疾病持续时间呈负相关。6例患者(5例女性和1例男性)T4值低于正常,其中4例FT4值也低于正常。没有患者出现低三碘甲状腺原氨酸(T3)和高三碘甲状腺原氨酸逆转运体(rT3)值,即没有患者表现出酮症酸中毒状态下所描述的“低T3综合征”的生化模式。这也表明所有患者的IDDM得到了满意的代偿。在研究时,没有患者(包括那些有循环MCHA和TGHA以及TSH对TRH反应亢进的患者)出现甲状腺肿大或甲状腺功能障碍的临床特征,包括生长发育受损和骨龄延迟。